×

Warning

Joomla\CMS\Cache\Storage\FileStorage::_deleteFolder Failed deleting 6757425499eac20291c301b132bc46c6-cache-mod_menu-b018f32973bc1519100f540023857bb7.php

nimbus-therapeutics-logo

Nimbus Therapeutics will have $43 million to progress clinical trials of its non-alcoholic liver disease drug after the company successfully completed a financing round.

The Series B investment was led by Pfizer Venture Investments and Lightstone Ventures. Previous investors, including Atlas Venture, SR One, Lilly Ventures and Bill Gates, also participated.